Få varsel ved oppdateringer av «About the speakers»
Du har meldt deg på nyhetsvarsel for:
About the speakers
Innhold på denne siden
Camilla is the leader of the Norwegian Institute of Public Health. She is also the institute’s contact with the political leaders in the Ministry of Health and Social Care.
Ragnhild Eek Brandlistuen
Dr. Ragnhild Eek Brandlistuen is a senior researcher in child development and epidemiology at the Norwegian Institute of Public Health and since 2021 the scientific director of MoBa. She has extensive experience with longitudinal studies on child development using MoBa data and she was head of the MoBaYoung data collection.
Her research focuses on understanding the impact of early risk and protective factors both prenatally and during the formative childhood and adolescent years for neurodevelopment, cognition, and mental health. Her research profile is interdisciplinary with collaborations spanning pharmacoepidemiology to early education research. She is actively involved in several ongoing MoBa-projects such as the Language and Learning Study, MoBaKinder, MoBaEarlyEd and C-Me.
Marte-Helene Bjørk is the leader of Bergen Epilepsy Research Groups that have published 18 papers from MoBa focusing on women with epilepsy. Recently the group extended their analytical approach to genetic epidemiology and epigenetics.
Bjørk is associated professor at the University of Bergen and senior consultant neurologist at Haukeland University Hospital.
Siri E. Håberg
Dr. Siri Håberg (MD PhD) is the Director of the Centre for Fertility and Health, a Centre of Excellence at the Norwegian Institute of Public Health. She has extensive experience with combining data from national registries, cohort studies, and biobanks.
Her research focuses on perinatal epidemiology, and she has a special interest in how prenatal exposures can influence child health.
Laurie Hannigan is a researcher based at the Nic Waals Institute, Lovisenberg Diaconal Hospital in Oslo, Norway, also working with the Norwegian Institute of Public Health and Bristol Medical School, University of Bristol. He obtained his PhD in Behavior Genetics from King’s in 2018 under the supervision of Prof. Thalia Eley and Dr. Tom McAdams. After a short postdoctoral position at the University of Glasgow’s Institute of Health and Wellbeing in 2018, he moved to Oslo to focus on genetic epidemiological work with the Norwegian Mother, Father, and Child Cohort study (MoBa). His research interests include studying within-family transmission of risk for psychiatric disorders, the aetiology and development of emotional and behavioural problems, factors influencing the emergence of neurodevelopmental conditions, patterns and consequences of comorbidity and multimorbidity, and methodological issues in the application of developmental genetic epidemiological approaches to birth cohort and population registry data sources.
Stefan Johansson is a professor at the Centre for Diabetes Research, University of Bergen and the Department of Medical Genetics (MGM), Haukeland University Hospital. His research interests relate to the identification and characterization of genetic variation influencing human traits. His work has led to the identification and publication of novel Mendelian disease genes in diabetes and brain related disorders, and the early establishment of next generation sequencing in the clinical diagnostics at the MGM.
He has also vast experience with genome wide association analyses across a wide range of disorders and traits. Stefan and his team were involved in the establishment, funding and QC-work of the first large-scale array genotyping efforts in MoBa that forms the basis of MoBaGenetics v1 release.
His research in MoBa aims at increasing our understanding of the mechanisms underlying our growth during the first years of life and how it relates to later health and disease.
Torkild Hovde Lyngstad
Lyngstad is a demographer and sociologist. He is currently leading the ERC Consolidator project OPENFLUX, which seeks to understand social change, the life course and intergenerational transmission by combining genetic and social science perspectives.
Johanne Haug Pettersen
Johanne is a PhD candidate in the Covid-19 and impact on mental health: a longitudinal, multi-national study (C-Me). My PhD project will be conducted in close collaboration with the PsychGen research group at the Norwegian Institute of Public Health (NIPH).
In her project she will use large datasets and molecular genetic methods to examine how genetic and environmental factors contributes to the development of mental health problems and disorders in childhood, adolescence and families related to the pandemic.
Ole A. Andreassen
Professor in psychiatry at the University of Oslo, Division of Mental Health and Addiction, and attending psychiatrist, Oslo University Hospital (OUH), Oslo, Norway. After a PhD at University of Bergen and post doc position at Massachusetts General Hospital-Harvard Medical School he finished his psychiatry residency at OUH and is now the Director of Norwegian Centre for Mental Disorders Research (NORMENT), one of the largest mental health research groups in Scandinavia. His research focuses on causes, disease mechanisms and outcome prediction of severe mental disorders, building on the Nordic advantages, such as public health care system, biobanks, health registries, and he runs a biostatistical research program to improve analysis and develop precision medicine tools.
Kristine Beate Walhovd
Professor Kristine Beate Walhovd, Center for Lifespan Changes in Brain and Cognition (LCBC), UiO.
Together with colleagues, I am trying to uncover markers and mechanisms underlying differences and changes in brain and cognitive function throughout the lifespan. In this effort, we’re studying persons ranging in age from 0-100 yrs, using brain scans and cognitive standardized and experimental tests, as well as training interventions. I am interested in the timing of influences, and believe there is a need to focus on what can be, and is, influenced when. Early life – including in utero- factors may have an impact on individual function at all ages, and we need to understand these also to understand what residual variance can be influenced at older ages.
Professor Bo Jacobsson (MD, PhD) is the head of Perinatal Research Laboratory at Sahlgrenska University Hospital, Gothenburg, Sweden and Senior researcher at Institute of Public Health, Oslo, Norway. He is a clinical scientist with a speciality in Obstetrics, Gynecology, and Maternal/Fetal Medicine.
He is a leading expert on the mechanisms and epidemiology of preterm birth.
Professor Jacobsson is the FIGO Division Director of Maternal and Neonatal Health 2021-2023 and has led the FIGO Working Group of Preterm Birth during 2019-2021. Professor Jacobsson is also part of the Partnership for Maternal, Newborn & Child Health, Knowledge and Evidence Working Group.
He is also on the Board of Directors of the European Association of Perinatal Medicine (EAPM) and chairs the EAPM Special Interest Group of Preterm Birth. Prof Jacobsson has more than 20 years been involved in the work of different international organizations around maternal and neonatal health like PREBIC and PREGENIA. He is presently leading the European Branch of PREBIC. He is a steering group member of Genomic Medicine Sweden and is chairing the Genomic Medicine Sweden complex diseases group. He is also a Swedish representative in the Nordic Society of Precision Medicine.
Prof. Jacobsson has published more than 300 per reviewed papers between 2002-2022. Among other journals, he has published in Nature, Science, New England Journal of Medicine, Nature Genetics, PLOS Medicine, and JAMA. In addition, he has been invited to lecture to more than 150 international scientific conferences.
Scientific Director at Centre for Fertility and Health (CeFH), NIPH
Per Magnus finished medical school in 1976 and subsequently specialized in medical genetics before joining the NIPH in 1985. Since then he has worked as a general epidemiologist and as head of/participant in various research groups. He has been preoccupied with MoBa since the early planning of the cohort in 1993.